Abstract

Parkinson’s disease (PD) is clinically defined by the presence of the cardinal motor symptoms, which are associated with a loss of dopaminergic nigrostriatal neurons in the substantia nigra pars compacta (SNpc). While SNpc neurons serve as the prototypical cell-type to study cellular vulnerability in PD, there is an unmet need to extent our efforts to other neurons at risk. The noradrenergic locus coeruleus (LC) represents one of the first brain structures affected in Parkinson’s disease (PD) and plays not only a crucial role for the evolving non-motor symptomatology, but it is also believed to contribute to disease progression by efferent noradrenergic deficiency. Therefore, we sought to characterize the electrophysiological properties of LC neurons in two distinct PD models: (1) in an in vivo mouse model of focal α-synuclein overexpression; and (2) in an in vitro rotenone-induced PD model. Despite the fundamental differences of these two PD models, α-synuclein overexpression as well as rotenone exposure led to an accelerated autonomous pacemaker frequency of LC neurons, accompanied by severe alterations of the afterhyperpolarization amplitude. On the mechanistic side, we suggest that Ca2+-activated K+ (SK) channels are mediators of the increased LC neuronal excitability, as pharmacological activation of these channels is sufficient to prevent increased LC pacemaking and subsequent neuronal loss in the LC following in vitro rotenone exposure. These findings suggest a role of SK channels in PD by linking α-synuclein- and rotenone-induced changes in LC firing rate to SK channel dysfunction.

Highlights

  • Parkinson’s disease (PD), the second most common neurodegenerative disorder, is a progressive, age-related movement disorder

  • Despite the early involvement in the prodromal phase of PD, only little is known about the functional consequences locus coeruleus (LC) neurons face during the course of PD

  • We aimed to elucidate the electrophysiological characteristics of LC neurons when rendered parkinsonian by either focal overexpression of human αSynWT or mutated αSynA53T, or by application of rotenone, a complex I inhibitor known to induce PD pathology in ­mice[38]

Read more

Summary

Introduction

Parkinson’s disease (PD), the second most common neurodegenerative disorder, is a progressive, age-related movement disorder It is characterized by the accumulation of α-synuclein (αSyn) positive eosinophilic neuronal inclusions, termed Lewy pathology, and neurodegeneration. Our experiments suggest that SK channels might represent valuable pharmacological targets for disease modifying therapy approaches, since application of the SK channel activator, 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) normalized LC firing frequency, but even counteracted neuronal LC loss in the in vitro rotenone model.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call